Legato Merger Corp. III (LEGT) - Total Liabilities
Based on the latest financial reports, Legato Merger Corp. III (LEGT) has total liabilities worth $7.04 Million USD as of February 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See working capital position of Legato Merger Corp. III to evaluate short-term liquidity relative to the company's equity base.
Legato Merger Corp. III - Total Liabilities Trend (2023–2025)
This chart illustrates how Legato Merger Corp. III's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see LEGT current and non-current assets.
Legato Merger Corp. III Competitors by Total Liabilities
The table below lists competitors of Legato Merger Corp. III ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Samyang Holdings
KO:000070
|
Korea | ₩2.59 Trillion |
|
Oak Valley Bancorp
NASDAQ:OVLY
|
USA | $1.82 Billion |
|
Aten International Co Ltd
TW:6277
|
Taiwan | NT$2.12 Billion |
|
Taeyoung Engineering & Construction Co.,Ltd.
KO:009415
|
Korea | ₩3.15 Trillion |
|
Shanghai Hile Bio-tech
SHG:603718
|
China | CN¥408.00 Million |
|
XinJiang GuoTong Pipeline Co Ltd
SHE:002205
|
China | CN¥3.40 Billion |
|
Biodesix Inc
NASDAQ:BDSX
|
USA | $86.18 Million |
|
Eyepoint Pharmaceuticals Inc
NASDAQ:EYPT
|
USA | $51.51 Million |
Liability Composition Analysis (2023–2025)
This chart breaks down Legato Merger Corp. III's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See LEGT net asset quality index to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | N/A | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.03 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.03 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Legato Merger Corp. III's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Legato Merger Corp. III (2023–2025)
The table below shows the annual total liabilities of Legato Merger Corp. III from 2023 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-11-30 | $7.04 Million | 0.00% |
| 2024-11-30 | $7.04 Million | +44656.32% |
| 2023-11-30 | $15.74K | -- |
About Legato Merger Corp. III
Legato Merger Corp. III does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other related business combination with one or more target businesses or entities. The company was incorporated in 2023 and is based in New York, New York.